Related Funds
Fund Name | Location |
Anblicks | - |
Applied Research Council | China, Hong Kong, Hong Kong Island |
Common Fund | Connecticut, United States, Wilton |
CPC & Partners | Canada, Ontario, Toronto |
CW Group | Connecticut, Greenwich, United States |
Gelt VC | California, Los Angeles, United States |
Kateeva | California, Newark, United States |
Nanyang Ventures | Australia, New South Wales, Sydney |
Neev Fund | India, Maharashtra, Mumbai |
NFX Ventures | - |
Pays de la Loire Participations | France, Nantes, Pays de la Loire |
Success Group | China, Foshan, Guangdong |
The Melohn Group | - |
TTSeed | Italy, Lombardia, Milano |
University of Pittsburgh Innovation Institute | Pennsylvania, Pittsburgh, United States |
Work.fund | - |
Wuxi Haohai Information Technology | Anhui, China, Wuxi |
Xinghao Venture Management Center | - |
Xinyuan Investment | - |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Amplifier Therapeutics | $33M | 17 Oct 2023 | - | ||
Vita Therapeutics | $31M | 12 Oct 2022 | Baltimore, Maryland, United States | ||
Oviva Therapeutics | $11M | 19 May 2022 | New York, New York, United States | ||
Vita Therapeutics | $32M | 23 Jun 2021 | Baltimore, Maryland, United States | ||
Arcellx | $115M | 13 Apr 2021 | Maryland, United States | ||
Sensei Biotherapeutics | $30M | 11 Jan 2021 | Maryland, United States | ||
Sensei Biotherapeutics | $28M | 07 Oct 2020 | Maryland, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Amplifier Therapeutics | $33M | 17 Oct 2023 | - | ||
Vita Therapeutics | $31M | 12 Oct 2022 | Baltimore, Maryland, United States | ||
Oviva Therapeutics | $11M | 19 May 2022 | New York, New York, United States | ||
Vita Therapeutics | $32M | 23 Jun 2021 | Baltimore, Maryland, United States | ||
Arcellx | $115M | 13 Apr 2021 | Maryland, United States | ||
Sensei Biotherapeutics | $30M | 11 Jan 2021 | Maryland, United States | ||
Sensei Biotherapeutics | $28M | 07 Oct 2020 | Maryland, United States |